AI News about drug pricing policy

Global Health Headlines: Drugs, Vaccines, and Policies in Focus | Health

European Drugmakers Delay New Medicine Launches Over Pricing Pressure European pharmaceutical companies are postponing new drug introductions amid stricter price policies influenced by US administration pressure. President Trump's most-favored-nation pricing strategy, which ties US drug costs to international prices, has prompted drugmakers to reconsider their market expansion timelines. The policy shift could delay patient access to innovative treatments across Europe.